| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T7 |
201-208 |
Sentence |
denotes |
Methods |
| T8 |
209-391 |
Sentence |
denotes |
Eleven GBS cases in four key COVID-19 hotspots are discussed regarding presenting symptoms, response to therapies and cross-reactivity of COVID spike proteins with nerve glycolipids. |
| T9 |
392-581 |
Sentence |
denotes |
Emerging cases of COVID-19–triggered autoimmune necrotizing myositis (NAM) and encephalopathies are also reviewed in the context of viral invasion, autoimmunity and ongoing immunotherapies. |
| T10 |
583-590 |
Sentence |
denotes |
Results |
| T11 |
591-815 |
Sentence |
denotes |
Collective data indicate that in this pandemic any patient presenting with an acute paralytic disease-like GBS, encephalomyelitis or myositis-even without systemic symptoms, may represent the first manifestation of COVID-19. |
| T12 |
816-932 |
Sentence |
denotes |
Anosmia, ageusia, other cranial neuropathies and lymphocytopenia are red flags enhancing early diagnostic suspicion. |
